UnitedHealth Group (NYSE:UNH) Price Target Raised to $478.00

UnitedHealth Group (NYSE:UNH) had its price objective lifted by stock analysts at Royal Bank Of Canada from $463.00 to $478.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage currently has an “outperform” rating on the healthcare conglomerate’s stock. Royal Bank Of Canada’s price objective would suggest a potential upside of 9.96% from the company’s previous close.

A number of other brokerages have also recently issued reports on UNH. Raymond James Financial raised shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price objective on the stock in a research note on Wednesday, April 1st. HC Wainwright set a $492.00 price target on UnitedHealth Group in a research report on Wednesday, May 27th. Robert W. Baird raised UnitedHealth Group from an “underperform” rating to a “neutral” rating and increased their target price for the company from $287.00 to $453.00 in a research note on Thursday. HSBC boosted their target price on UnitedHealth Group from $300.00 to $380.00 and gave the stock a “hold” rating in a research report on Monday, July 6th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, June 11th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $440.79.

UnitedHealth Group Trading Up 2.7%

Shares of UNH opened at $434.69 on Friday. The stock’s fifty day simple moving average is $403.87 and its 200-day simple moving average is $341.69. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $394.76 billion, a PE ratio of 32.85, a price-to-earnings-growth ratio of 1.68 and a beta of 0.62. UnitedHealth Group has a 12-month low of $234.60 and a 12-month high of $461.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, topping the consensus estimate of $4.87 by $1.51. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The firm had revenue of $112.03 billion during the quarter, compared to analysts’ expectations of $110.81 billion. During the same period in the previous year, the business posted $4.08 EPS. The company’s quarterly revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, research analysts predict that UnitedHealth Group will post 18.39 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the sale, the chief executive officer owned 17,805 shares of the company’s stock, valued at $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.28% of the company’s stock.

Institutional Trading of UnitedHealth Group

Several hedge funds and other institutional investors have recently modified their holdings of the company. Ares Financial Consulting LLC grew its holdings in shares of UnitedHealth Group by 7.2% during the second quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock worth $174,000 after buying an additional 28 shares in the last quarter. Founders Capital Management LLC grew its stake in shares of UnitedHealth Group by 3.0% during the 4th quarter. Founders Capital Management LLC now owns 982 shares of the healthcare conglomerate’s stock worth $324,000 after acquiring an additional 29 shares in the last quarter. Kellett Wealth Advisors LLC lifted its position in shares of UnitedHealth Group by 1.7% in the fourth quarter. Kellett Wealth Advisors LLC now owns 1,746 shares of the healthcare conglomerate’s stock worth $576,000 after purchasing an additional 29 shares in the last quarter. Rockland Trust Co. boosted its holdings in UnitedHealth Group by 1.1% during the second quarter. Rockland Trust Co. now owns 2,589 shares of the healthcare conglomerate’s stock worth $1,076,000 after purchasing an additional 29 shares during the last quarter. Finally, Matrix Trust Co increased its stake in UnitedHealth Group by 24.8% in the 2nd quarter. Matrix Trust Co now owns 146 shares of the healthcare conglomerate’s stock valued at $61,000 after buying an additional 29 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth beat Q2 expectations on both revenue and EPS, with adjusted EPS of $6.38 versus estimates around $4.87-$4.94 and revenue of $112.03 billion above consensus. The company said lower medical costs and improved Optum operating income helped drive the outperformance. UnitedHealth Group Reports Second Quarter 2026 Results
• Positive Sentiment: Management raised full-year 2026 guidance to $19.50-$20.00 in adjusted EPS, signaling confidence that the turnaround is gaining traction and that cost control is improving profitability. UnitedHealth raises 2026 forecast as it controls medical costs
• Positive Sentiment: The company also boosted its buyback plan to at least $5 billion for 2026, which investors often view as a sign of confidence and a support for per-share earnings. What’s Fueling UNH Stock’s Rally? A Bigger Buyback, Higher Guidance – And CEO Says Turnaround Is ‘Returning To Form’
• Positive Sentiment: Analysts turned more constructive after the report, including UBS raising its price target to $490 from $460 and maintaining a Buy rating, which reinforces the rally. UBS price target raise
• Positive Sentiment: Robert W. Baird also upgraded the stock to Neutral from Underperform and sharply lifted its price target, adding to the wave of analyst optimism. Robert W. Baird upgrade
• Neutral Sentiment: Broader healthcare-sector strength and a favorable market backdrop may be providing some additional tailwind, but the main driver is still UnitedHealth’s own earnings and outlook. Use These ETFs as Health Stocks LLY, UNH, MRK Thrive

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.